These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2439814)

  • 41. Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease.
    Righetti A; Mérier G; Viquerat C; Ratib O; Rutishauser W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S39-41. PubMed ID: 2439817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect.
    Holmes D; Fryda-Kaurimsky Z; Krueger K
    Cardiology; 1990; 77(6):459-65. PubMed ID: 1981493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of various combination therapies based on a calcium antagonist in essential hypertension: results of a placebo-controlled randomized trial.
    Lüscher TF; Waeber B
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):305-9. PubMed ID: 7679166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypotensive effect of bopindolol in pithed rats.
    Tanaka H; Takahashi S; Shigenobu K
    Gen Pharmacol; 1993 Mar; 24(2):373-5. PubMed ID: 8097742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of bopindolol on renal function.
    Fabre J; Wintsch J; Peter-Contesse R; Bouchardy C; Liniger C; Favre L; Donath A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S45-50. PubMed ID: 2439819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
    Dzúrik R; Fetkovská N; Dvorák I; Jonás P; Markuljak I; Petr P; Kotlík I; Widimský J
    Cor Vasa; 1990; 32(2 Suppl 1):42-53. PubMed ID: 1974488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S12-5. PubMed ID: 2439811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action.
    Carboni GP; Scardovi AB; D'Ermo M; Prati PL
    Br J Clin Pharmacol; 1991 Dec; 32(6):755-7. PubMed ID: 1685090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity.
    Bolli P; Amann FW; Müller FB; Meyer B; Burckhardt D; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S64-9. PubMed ID: 2439824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
    Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
    J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension.
    Abrahamsen AM; Digranes O; Gisholt K
    J Intern Med; 1990 Sep; 228(3):219-22. PubMed ID: 2205704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
    Hosohata Y; Sasaki K; Maruyama K; Ohnuki T; Hattori K; Suzuki J; Watanabe K; Nagatomo T
    Biol Pharm Bull; 1996 Jul; 19(7):932-5. PubMed ID: 8839963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.
    Walden RJ; Tomlinson B; Graham B; Liu JB; Prichard BN
    Br J Clin Pharmacol; 1990 Oct; 30(4):557-65. PubMed ID: 1981318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
    Fodor JG; Chockalingam A; Drover A; Fifield F; Pauls CJ
    J Clin Pharmacol; 1987 Nov; 27(11):892-901. PubMed ID: 2892865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the antihypertensive effects of betaxolol to atenolol.
    Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
    Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.